Will Lumen's FY2026 adjusted EBITDA exceed FY2025 adjusted EBITDA (pro forma ex-consumer)?
Current Prediction
Prediction History
April filings do not directly affect operating EBITDA (interest savings flow to FCF, not EBITDA). Pro forma base already excludes divested consumer. Model agreement tightened as execution track record improved.
Why This Question Matters
EBITDA inflection in 2026 is the 3rd of 4 stated turnaround goals. If achieved, it validates cost savings and revenue mix improvement. If missed, the 2028 revenue target loses credibility.
Prediction Distribution
Individual Predictions(9 runs)
April filings do not materially change EBITDA outlook. Capital structure actions affect interest, not operating EBITDA. Baseline 0.74 holds.
Cost savings trajectory $400M to $700M supports EBITDA growth on pro forma base. Revenue decline is the swing.
Management credibility improved with April execution; 3rd of 4 milestones (EBITDA inflection) likely delivered.
Pro forma base excludes divested consumer; cost savings on continuing ops support growth.
EBITDA guidance $3.1-3.3B vs pro forma ex-consumer FY2025; cost savings do the work.
April execution confirms management discipline on stated plan.
Baseline 0.74 holds; April filings do not directly change operating outlook.
Cost savings delivering; pro forma EBITDA growth achievable.
Management credibility improved marginally with April execution.
Resolution Criteria
Resolves YES if FY2026 adjusted EBITDA exceeds FY2025 pro forma adjusted EBITDA (excluding divested consumer business).
Resolution Source
Lumen Q4 2026 Earnings Release
Source Trigger
EBITDA inflection guided for 2026
Full multi-lens equity analysis